Company: CELH
Filing Date: 2025-03-12
Form Type: 8-K
Source: 0001341766-25-000056
Chunk: 0

Company: Celsius Holdings, Inc.
Filing Date: 2025-03-12
Form: 8-K
Item: Item 7.01
Chunk 0
---
Item 7.01

Regulation FD Disclosure.

On February 20, 2025, Celsius Holdings, Inc. (the “ Company”), announced that it had entered into a Membership Interest Purchase Agreement (the “ Purchase Agreement”) to purchase all of the issued and outstanding membership interests in Alani Nutrition LLC (“ Alani Nu”), a Kentucky limited liability company (the “ Transaction”), subject to the satisfaction of certain customary closing conditions, including the expiration of the waiting period (the “ Waiting Period”) applicable to the Transaction under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended. The Waiting Period expired on March 10, 2025, satisfying one of the closing conditions necessary for completing the Transaction. The Company currently expects to close the Transaction as early as April 2025.

The information contained in Item 7.01 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Cautionary Statement Regarding Forward-Looking Statements

Certain statements made herein are not historical facts but are considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include the expected timing of the closing of the Transaction. You can identify these statements by the use of words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will,” “would,” “could,” “project,” “plan,” “potential,” “designed,” “seek,” “target,” and variations of these terms, the negatives of such terms and similar expressions. You should not rely on forward-looking statements because Celsius’ actual results may differ materially from those indicated by forward-looking statements as a result of a number of important factors. These factors include but are not limited to: the risk that the closing conditions for the Transaction will not be satisfied, including the risk that clearance under applicable antitrust laws other than the Hart-Scott-Rodino Antitrust Improvements Act will not be obtained; the risk that the Purchase Agreement will be terminated prior to closing; the possibility that the Transaction will not